Talphera (TLPH) Depreciation & Amortization (CF) (2010 - 2023)
Talphera (TLPH) posted quarterly Depreciation & Amortization (CF) of $49000.0 for Q2 2023, down 89.37% year-over-year from $461000.0 in Q2 2022, and down 81.3% quarter-over-quarter from $262000.0 in Q1 2023.
Talphera (TLPH) Depreciation & Amortization (CF) (2010 - 2023) Analysis & Trends
Talphera's Depreciation & Amortization (CF) history runs 14 years deep, the most recent figure standing at $49000.0 for Q2 2023.
- In Q2 2023, Depreciation & Amortization (CF) fell 89.37% year-over-year to $49000.0; the TTM figure through Mar 2024 stood at $49000.0 (down 96.71% YoY), while the FY2023 annual figure was $311000.0, down 81.12% from the prior year.
- Depreciation & Amortization (CF) for Q2 2023 stood at $49000.0, down from $262000.0 in the prior quarter.
- The five-year high for Depreciation & Amortization (CF) was $579000.0 in Q2 2021, with the low at $49000.0 in Q2 2023.
- The 5-year median for Depreciation & Amortization (CF) is $437000.0 (2021), against an average of $414000.0.
- The sharpest annual moves came in 2019 and 2023: Depreciation & Amortization (CF) jumped 267.86% in 2019, then slumped 89.37% in 2023.
- Talphera's Depreciation & Amortization (CF) stood at $515000.0 in 2019, then dropped by 25.83% to $382000.0 in 2020, then increased by 20.68% to $461000.0 in 2021, then dropped by 25.81% to $342000.0 in 2022, then plunged by 85.67% to $49000.0 in 2023.
- Business Quant data shows TLPH's Depreciation & Amortization (CF) at $49000.0 in Q2 2023, $262000.0 in Q1 2023, and $342000.0 in Q4 2022.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation & Amortization (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.51 Bn | 43.55 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.52 Bn | 39.86 Bn | 2.15 Bn | 241.00 Mn |
| 3 | Zoetis | 32.43 Bn | 30.75 Bn | 1.05 Bn | 119.00 Mn |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn | 1.02 Bn |
| 5 | United Therapeutics | 21.87 Bn | 19.21 Bn | 683.80 Mn | 24.20 Mn |
| 6 | Viatris | 18.98 Bn | 18.09 Bn | 1.46 Bn | 672.30 Mn |
| 7 | Neurocrine Biosciences | 15.43 Bn | 15.04 Bn | 935.80 Mn | - |
| 8 | Elanco Animal Health | 12.02 Bn | 11.49 Bn | 798.00 Mn | 171.00 Mn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - | - |
| 10 | Talphera | 90.25 Mn | 90.25 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2023 | 49,000.00 |
| Jun 30, 2023 | 49,000.00 |
| Mar 31, 2023 | 262,000.00 |
| Mar 31, 2023 | 262,000.00 |
| Dec 31, 2022 | 342,000.00 |
| Dec 31, 2022 | 342,000.00 |
| Sep 30, 2022 | 424,000.00 |
| Sep 30, 2022 | 424,000.00 |
| Jun 30, 2022 | 461,000.00 |
| Jun 30, 2022 | 461,000.00 |
| Mar 31, 2022 | 420,000.00 |
| Mar 31, 2022 | 420,000.00 |
| Dec 31, 2021 | 461,000.00 |
| Dec 31, 2021 | 461,000.00 |
| Sep 30, 2021 | 483,000.00 |
| Sep 30, 2021 | 483,000.00 |
| Jun 30, 2021 | 579,000.00 |
| Jun 30, 2021 | 579,000.00 |
| Mar 31, 2021 | 450,000.00 |
| Mar 31, 2021 | 450,000.00 |